Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot2: STU1 Ballot 2) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions

Example EvidenceVariable: OutcomeDefinition: Serious hyperglycaemia

Page standards status: Informative

Generated Narrative: EvidenceVariable 236974

version: 66; Last updated: 2025-03-20 18:40:09+0000

RelatesTo

  • type: part-of
  • targetReference: MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)

url: EvidenceVariable OutcomeDefinition: Serious hyperglycaemia

identifier: FEvIR Object Identifier/https://fevir.net/FOI/236974, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-313963, outcomeId/313963, picoId/85798, sectionId/73215, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.76

version: 1.0.0-ballot2

name: Serious_hyperglycaemia313963

title: OutcomeDefinition: Serious hyperglycaemia

shortTitle: Serious hyperglycaemia

status: Active

date: 2025-03-28 17:11:38+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

Serious hyperglycaemia

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

author: Computable Publishing®: MAGIC-to-FEvIR Converter:

handling: dichotomous variable